The phospholipid binding protein, annexin A5 (AnxA5), has potent anticoagulant properties that result from its forming 2-dimensional crystals over phospholipids, blocking the availability of the phospholipids for critical coagulation enzyme reactions. This article reviews the evidence that antiphospholipid antibodies can disrupt this anticoagulant shield and unmask thrombogenic anionic phospholipids, which may thereby contribute to thrombosis in patients with the antiphospholipid syndrome (APS). This mechanism for thrombosis in APS can be monitored with coagulation assays for resistance to anticoagulant activity of AnxA5.
1 Giannakopoulos B Passam F Rahgozar S Krilis SA . Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood2007; 109: 422–430.
2.
2 Funakoshi T Heimark RL Hendrickson LE McMullen BA Fujikawa K . Human placental anticoagulant protein: isolation and characterization. Biochemistry1987; 26: 5572–5578.
3.
3 Tait JF Sakata M McMullen BA . Placental anticoagulant proteins: isolation and comparative characterization four members of the lipocortin family. Biochemistry1988; 27: 6268–6276.
4.
4 Mosser G Ravanat C Freyssinet JM Brisson A . Sub-domain structure of lipid-bound annexin-V resolved by electron image analysis. J Mol Biol1991; 217: 241–245.
5.
5 Voges D Berendes R Burger A Demange P Baumeister W Huber R . Three-dimensional structure of membrane-bound annexin, V. A correlative electron microscopy-X-ray crystallography study. J Mol Biol1994; 238: 199–213.
6.
6 Reviakine I Bergsma-Schutter W Brisson A . Growth of protein 2-D crystals on supported planar lipid bilayers imaged in situ by AFM. J Struct Biol1998; 121: 356–361.
7.
7 Oling F Bergsma-Schutter W Brisson A . Trimers, dimers of trimers, and trimers of trimers are common building blocks of annexin a5 two-dimensional crystals. J Struct Biol2001; 133: 55–63.
8.
8 Andree HAM Stuart MC Hermens WT . Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem1992; 267: 17907–17912.
9.
9 Mo Y Campos B Mealy TR . Interfacial basic cluster in annexin V couples phospholipid binding and trimer formation on membrance surfaces. J Biol ChemXXX; 278: 2437–2443.
10.
10 Gerke V Moss SE . Annexins: from structure to function. Physiol Rev2002; 82: 331–371.
11.
11 Reutelingsperger CP Kop JM Hornstra G Hemker HC . Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid- dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids. Eur J Biochem1988; 173: 171–178.
12.
12 Andree HA Reutelingsperger CP Hauptmann R Hemker HC Hermens WT Willems GM . Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem1990; 265: 4923–4928.
13.
13 Tait JF Gibson D Fujikawa K . Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem1989; 264: 7944–7949.
14.
14 Krikun G Lockwood CJ Wu XX . The expression of the placental anticoagulant protein, annexin, V, by villous trophoblasts: immunolocalization and in vitro regulation. Placenta1994; 15: 601–612.
15.
15 Rand JH Wu XX Andree HA . Pregnancy loss in the antiphospholipid-antibody syndrome–a possible thrombogenic mechanism. N Engl J Med1997; 337: 154–160.
16.
16 Vogt E Ng AK Rote NS . Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation. Am J Obstet Gynecol1997; 177: 964–972.
17.
17 Wang X Campos B Kaetzel MA Dedman JR . Annexin V is critical in the maintenance of murine placental integrity. Am J Obstet Gynecol1999; 180: 1008–1016.
18.
18 Brachvogel B Dikschas J Moch H . Annexin A5 is not essential for skeletal development. Mol Cell Biol2003; 23: 2907–2913.
19.
19 de Laat B Derksen RH Mackie IJ . Annexin A5 polymorphism (-1C–>T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. Ann Rheum Dis2006; 65: 1468–1472.
20.
20 Rand JH Wu XX Guller S . Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obstet Gynecol1994; 171: 1566–1572.
21.
21 Shu F Sugimura M Kanayama N Kobayashi H Kobayashi T Terao T . Immunohistochemical study of annexin V expression in placentae of preeclampsia. Gynecol Obstet Invest2000; 49: 17–23.
22.
22 Bogdanova N Horst J Chlystun M . A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss. Hum Mol Genet2007; 16: 573–578.
23.
23 Kaburaki J Kuwana M Yamamoto M Kawai S Ikeda Y . Clinical significance of anti-annexin V antibodies in patients with systemic lupus erythematosus. Am J Hematol1997; 54: 209–213.
24.
24 Satoh A Suzuki K Takayama E . Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus. J Rheumatol1999; 26: 1715–1720.
25.
25 Sugiura K Muro Y . Anti-annexin V antibodies and digital ischemia in patients with scleroderma. J Rheumatol1999; 26: 2168–2172.
26.
26 Zammiti W Mtiraoui N Hidar S Fekih M Almawi WY Mahjoub T . Antibodies to beta2-glycoprotein I and annexin V in women with early and late idiopathic recurrent spontaneous abortions. Arch Gynecol Obstet2006; 274: 261–265.
27.
27 Zammiti W Mtiraoui N Kallel C Mercier E Almawi WY Mahjoub T . A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V. Reproduction2006; 131: 817–822.
28.
28 Martinez L; Basi N; Dordal A; Roser R; Sagarra R; . A pharmacokinetic study of E-4441, a new quinolone, in the rat, mouse and cynomolgus monkey. Eur J Drug Metab Pharmacokinet 1991; Spec No 3: 352–356.
29.
29 Siaka C Lambert M Caron C . Low prevalence of anti-annexin V antibodies in antiphospholipid syndrome with fetal loss. Rev Med Interne1999; 20: 762–765.
30.
30 Ogawa H Zhao D Dlott JS . Elevated anti-annexin V antibody levels in antiphospholipid syndrome and their involvement in antiphospholipid antibody specificities. Am J Clin Pathol2000; 114: 619–628.
31.
31 Arai T Matsubayashi H Sugi T . Anti-annexin A5 antibodies in reproductive failures in relation to antiphospholipid antibodies and phosphatidylserine. Am J Reprod Immunol2003; 50: 202–208.
32.
32 Rand JH Arslan AA Wu XX . Reduction of circulating annexin A5 levels and resistance to annexin A5 anticoagulant activity in women with recurrent spontaneous pregnancy losses. Am J Obstet Gynecol2006; 194: 182–188.
33.
33 Lakasing L Campa JS Poston R Khamashta MA Poston L . Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome. Am J Obstet Gynecol1999; 181: 180–189.
34.
34 Cederholm A Svenungsson E Jensen-Urstad K . Decreased binding of annexin V to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus. Arterioscler Thromb Vasc Biol2005; 25: 198–203.
35.
35 Rand JH Wu XX Andree HAM . Antiphospholipid antibodies accelerate plasma coagulation by inhibiting annexin-V binding to phospholipids: a "lupus procoagulant" phenomenon. Blood1998; 92: 1652–1660.
36.
36 Hanly JG Smith SA . Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome. Clin Exp Immunol2000; 120: 537–543.
37.
37 Tomer A . Antiphospholipid antibody syndrome: rapid, sensitive, and specific flow cytometric assay for determination of anti-platelet phospholipid autoantibodies. J Lab Clin Med2002; 139: 147–154.
38.
38 Tomer A Bar-Lev S Fleisher S Shenkman B Friger M Abu-Shakra M . Antiphospholipid antibody syndrome: the flow cytometric annexin A5 competition assay as a diagnostic tool. Br J Haematol2007; 139: 113–120.
39.
39 Rand JH Wu XX Quinn AS . Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Am J Pathol2003; 163: 1193–1200.
40.
40 Gaspersic N Ambrozic A Bozic B Majhenc J Svetina S Rozman B . Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies. Rheumatology (Oxford)2007; 46: 81–86.
41.
41 de Laat B Wu XX van Lummel M Derksen RHWM de Groot PG Rand JH . Correlation between antiphospholipid antibodies that recognize domain i of β2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. Blood2007; 109: 1490–1494.
42.
42 Willems GM Janssen MP Comfurius P Galli M Zwaal RF Bevers EM . Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes. Biochemistry2000; 39: 1982–1989.
43.
43 Rand JH Wu XX Lapinski R . Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood2004; 104: 2783–2790.
44.
44 Wu XX Pierangeli SS Rand JH . Resistance to annexin A5 binding and anticoagulant activity in plasmas from patients with the antiphospholipid syndrome but not with syphilis. J Thromb Haemost2006; 4: 271–273.
45.
45 Wu XX Arslan AA Wein R . Analysis of circulating annexin A5 parameters during pregnancy: absence of differences between women with recurrent spontaneous pregnancy losses and controls. Am J Obstet Gynecol2006; 195: 971–978.
46.
46 Lutters BC Meijers JC Derksen RH Arnout J de Groot PG . Dimers of beta 2-glycoprotein I mimic the in vitro effects of beta 2-glycoprotein I-anti-beta 2-glycoprotein I antibody complexes. J Biol Chem2001; 276: 3060–3067.
